Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Showing 1 - 1 of 1 results

First page disabled
Previous page disabled
1
Next page disabled
Next page disabled

DI-N-OCTYL SODIUM SULFOSUCCINATE

4YLY5570Y0

Search for Structure

Status:

Possibly Marketed Outside US

Source:

KETOSEB by Ceva Sante Animale

(2016)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=50af00f2-4a8d-4d1a-a27a-758f2bcf1a61

First approved in 2016

Source:

KETOSEB by Ceva Sante Animale

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=50af00f2-4a8d-4d1a-a27a-758f2bcf1a61

Class (Stereo):

CHEMICAL (RACEMIC)

Structure of DI-N-OCTYL SODIUM SULFOSUCCINATE

RACEMIC

DI-N-OCTYL SODIUM SULFOSUCCINATE

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1